找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Immuntherapie in der Uroonkologie; Herbert Rübben,Mark Goepel,Bernd J. Schmitz-Dräger Conference proceedings 1993 Springer-Verlag Berlin H

[复制链接]
查看: 38431|回复: 56
发表于 2025-3-21 20:05:03 | 显示全部楼层 |阅读模式
书目名称Immuntherapie in der Uroonkologie
编辑Herbert Rübben,Mark Goepel,Bernd J. Schmitz-Dräger
视频video
图书封面Titlebook: Immuntherapie in der Uroonkologie;  Herbert Rübben,Mark Goepel,Bernd J. Schmitz-Dräger Conference proceedings 1993 Springer-Verlag Berlin H
出版日期Conference proceedings 1993
关键词Adjuvante Therapie; Antikörper; Grundlagenforschung; Harnblasenkrebs; Interferon; Karzinom; Kombinationsth
版次1
doihttps://doi.org/10.1007/978-3-642-77830-8
isbn_softcover978-3-642-77831-5
isbn_ebook978-3-642-77830-8
copyrightSpringer-Verlag Berlin Heidelberg 1993
The information of publication is updating

书目名称Immuntherapie in der Uroonkologie影响因子(影响力)




书目名称Immuntherapie in der Uroonkologie影响因子(影响力)学科排名




书目名称Immuntherapie in der Uroonkologie网络公开度




书目名称Immuntherapie in der Uroonkologie网络公开度学科排名




书目名称Immuntherapie in der Uroonkologie被引频次




书目名称Immuntherapie in der Uroonkologie被引频次学科排名




书目名称Immuntherapie in der Uroonkologie年度引用




书目名称Immuntherapie in der Uroonkologie年度引用学科排名




书目名称Immuntherapie in der Uroonkologie读者反馈




书目名称Immuntherapie in der Uroonkologie读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:29:52 | 显示全部楼层
发表于 2025-3-22 01:08:32 | 显示全部楼层
发表于 2025-3-22 06:19:14 | 显示全部楼层
发表于 2025-3-22 10:31:58 | 显示全部楼层
G. Hofmockel,D. Heimbach,M. Wirth,B. Maurer-Schulzef these settings has unique requirements for diagnostic laboratory services; therefore the design of laboratory services depends highly on the environment in which it operates. Virtually every consideration in clinical laboratory design and function—personnel, equipment, automation, consolidation, t
发表于 2025-3-22 14:59:54 | 显示全部楼层
发表于 2025-3-22 20:00:32 | 显示全部楼层
W. Birchmeier,K. M. Weidner,J. Schipper,J. Behrenscertain cardiac and overall operative risk in addition to order the necessary tests for the patient preoperatively, it is ultimately the responsibility of the surgeon to assure that the patient undergoing the surgery is properly evaluated and counseled to have good clinical outcomes.
发表于 2025-3-22 22:33:15 | 显示全部楼层
发表于 2025-3-23 04:54:14 | 显示全部楼层
发表于 2025-3-23 09:17:37 | 显示全部楼层
S. Silletti,A. Razvidence for clinical utility, the emergence of genomic data standards, and examples of systems of pharmacogenomic prescribing. We conclude that the opportunities for genomic-guided therapy will likely increase over time. Clinical informatics development will be required to meet rapidly evolving need
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-15 21:27
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表